Vikas Sinha - 20 Oct 2022 Form 4/A - Amendment Insider Report for Allovir, Inc. (ALVR)

Role: Officer, Director, 10%+ Owner
Signature: /s/ Brett Hagen, as Attorney-in-Fact
Issuer symbol: ALVR
Transactions as of: 20 Oct 2022
Transactions value $: -$13,564
Form type: 4/A - Amendment
Filing time: 26 Oct 2022, 16:15:15 UTC
Date Of Original Report: 24 Oct 2022
Previous filing: 24 Oct 2022
Next filing: 23 Jan 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ALVR	Common Stock	Sale	-$13.6K	-1.45K	-0.14%	$9.36	1.04M	20 Oct 2022	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units, and does not represent a discretionary trade by the Reporting Person.
F2	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.08 to $9.72. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Remarks:

This Form 4/A is being filed correct the transaction date reported in the original Form 4 filed on October 24, 2022. Officer Title: President and Chief Financial Officer